Results for tag: "Alglucosidase Alfa"

Alglucosidase Alfa is a drug used to treat endocrine and metabolic disorders. It is a recombinant form of the human enzyme acid alpha-glucosidase, which is deficient in patients with Pompe disease. The drug is administered intravenously and helps to break down glycogen in the body, allowing for improved muscle function. It is also used to treat other metabolic disorders such as Gaucher disease and Fabry disease. Alglucosidase Alfa is a relatively new drug, with the first approved product being launched in 2006. Since then, several other products have been approved, with some being developed specifically for pediatric use. The market for Alglucosidase Alfa is growing, with more products being developed and approved for use. Some companies in the Alglucosidase Alfa market include Genzyme Corporation, Shire Pharmaceuticals, and Sanofi-Aventis. Other companies such as Amicus Therapeutics, BioMarin Pharmaceuticals, and Ultragenyx Pharmaceuticals are also involved in the development of Alglucosidase Alfa products. Show Less Read more